CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Monica Bertagnolli Lindsay Anne Renfro Leonard B. Saltz |
| Publication date | May 21, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |